Literature DB >> 19327966

Selective regulation of autoreactive B cells by FcgammaRIIB.

Jeganathan Venkatesh1, Daisuke Kawabata, Sunjung Kim, Xiaonan Xu, Prameladevi Chinnasamy, Elahna Paul, Betty Diamond, Christine M Grimaldi.   

Abstract

FcgammaRIIB is an inhibitory receptor which plays a role in limiting B cell and DC activation. Since FcgammaRIIB is known to dampen the signaling strength of the BCR, we wished to determine the impact of FcgammaRIIB on the regulation of BCRs which differ in their affinity for DNA. For these studies, FcgammaRIIB deficient BALB/c mice were bred with mice expressing the transgene-encoded H chain of the R4A anti-DNA antibody which gives rise to BCRs which express high, low or no affinity for DNA. The deletion of FcgammaRIIB in R4A BALB/c mice led to an alteration in the B cell repertoire, allowing for the expansion and activation of high affinity DNA-reactive B cells. By 6-8 months of age, R4A x FcgammaRIIB-/- BALB/c mice spontaneously developed anti-DNA antibody titers. These mice also displayed an induction of IFN-inducible genes and an elevation in levels of the B cell survival factor, BAFF. These data demonstrate that FcgammaRIIB preferentially limits activation of high affinity autoreactive B cells and can influence the activation of DC through an immune complex-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327966      PMCID: PMC2688718          DOI: 10.1016/j.jaut.2009.02.009

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  65 in total

1.  FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.

Authors:  Hajime Kono; Chieko Kyogoku; Takeshi Suzuki; Naoyuki Tsuchiya; Hiroaki Honda; Kazuhiko Yamamoto; Katsushi Tokunaga; Zen-Ichiro Honda
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

2.  Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts.

Authors:  R Andres Floto; Menna R Clatworthy; Karen R Heilbronn; Dalya R Rosner; Paul A MacAry; Angela Rankin; Paul J Lehner; Willem H Ouwehand; Janet M Allen; Nicholas A Watkins; Kenneth G C Smith
Journal:  Nat Med       Date:  2005-09-18       Impact factor: 53.440

3.  Induction of tolerance in arthritogenic B cells with receptors of differing affinity for self-antigen.

Authors:  Haochu Huang; John F Kearney; Michael J Grusby; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

4.  Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis.

Authors:  Hong Xin; Sanjay D'Souza; Trine N Jørgensen; Andrew T Vaughan; Peter Lengyel; Brian L Kotzin; Divaker Choubey
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

5.  Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus.

Authors:  Marissa C Blank; Radu N Stefanescu; Emi Masuda; Francesc Marti; Philip D King; Patricia B Redecha; Robert J Wurzburger; Margaret G E Peterson; Shizuko Tanaka; Luminita Pricop
Journal:  Hum Genet       Date:  2005-05-14       Impact factor: 4.132

6.  Failed up-regulation of the inhibitory IgG Fc receptor Fc gamma RIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the Fc gamma RIIB gene.

Authors:  Ziaur S M Rahman; Tim Manser
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

7.  Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint.

Authors:  Christine M Grimaldi; Venkatesh Jeganathan; Betty Diamond
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

8.  Cutting Edge: Hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells.

Authors:  Jeganathan Venkatesh; Elena Peeva; Xiaonan Xu; Betty Diamond
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

9.  Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion.

Authors:  Xinrui Li; Kaihong Su; Chuanyi Ji; Alexander J Szalai; Jianming Wu; Yan Zhang; Tong Zhou; Robert P Kimberly; Jeffrey C Edberg
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

10.  Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE.

Authors:  Meggan Mackay; Anfisa Stanevsky; Tao Wang; Cynthia Aranow; Margaret Li; Scott Koenig; Jeffrey V Ravetch; Betty Diamond
Journal:  J Exp Med       Date:  2006-08-21       Impact factor: 14.307

View more
  10 in total

1.  B cell depletion therapy exacerbates murine primary biliary cirrhosis.

Authors:  Amy Dhirapong; Ana Lleo; Guo-Xiang Yang; Koichi Tsuneyama; Robert Dunn; Marilyn Kehry; Thomas A Packard; John C Cambier; Fu-Tong Liu; Keith Lindor; Ross L Coppel; Aftab A Ansari; M Eric Gershwin
Journal:  Hepatology       Date:  2010-12-28       Impact factor: 17.425

2.  Marginal zone B cells are naturally reactive to collagen type II and are involved in the initiation of the immune response in collagen-induced arthritis.

Authors:  Cecilia Carnrot; Kajsa E Prokopec; Kristina Råsbo; Mikael Ci Karlsson; Sandra Kleinau
Journal:  Cell Mol Immunol       Date:  2011-02-28       Impact factor: 11.530

3.  Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.

Authors:  Muthusamy Thiruppathi; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  J Autoimmun       Date:  2014-01-02       Impact factor: 7.094

Review 4.  Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus.

Authors:  Divaker Choubey; Ravichandran Panchanathan; Xin Duan; Hongqi Liu; Hongzhu Liu
Journal:  J Interferon Cytokine Res       Date:  2011-09-08       Impact factor: 2.607

Review 5.  Lessons from an anti-DNA autoantibody.

Authors:  Joel Cohen-Solal; Betty Diamond
Journal:  Mol Immunol       Date:  2011-01-07       Impact factor: 4.407

6.  Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.

Authors:  Francesca Bernuzzi; Daniela Fenoglio; Florinda Battaglia; Marco Fravega; M Eric Gershwin; Francesco Indiveri; Aftab A Ansari; Mauro Podda; Pietro Invernizzi; Gilberto Filaci
Journal:  J Autoimmun       Date:  2010-07-16       Impact factor: 7.094

7.  Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases.

Authors:  Vera Gesheva; Zsuzsanna Szekeres; Nikolina Mihaylova; Iliyana Dimitrova; Maria Nikolova; Anna Erdei; Jozsef Prechl; Andrey Tchorbanov
Journal:  Hum Gene Ther Methods       Date:  2012-11-23       Impact factor: 2.396

8.  High-dose methylprednisolone pulse therapy upregulated FcγRIIb expression on B cells in primary Sjögren's syndrome patients with thrombocytopenia.

Authors:  Haifeng Chen; Shiliang Zhou; Dinglei Su; Liwei Lu; Xia Li; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2013-08-06       Impact factor: 2.980

9.  Could the expression of CD86 and FcγRIIB on B cells be functionally related and involved in driving rheumatoid arthritis?

Authors:  Claudia Mauri; Elizabeth C Jury
Journal:  Arthritis Res Ther       Date:  2010-08-13       Impact factor: 5.156

10.  Regulation of allograft survival by inhibitory FcγRIIb signaling.

Authors:  Chris J Callaghan; Thet Su Win; Reza Motallebzadeh; Thomas M Conlon; Manu Chhabra; Inês Harper; Siva Sivaganesh; Eleanor M Bolton; J Andrew Bradley; Rebecca J Brownlie; Kenneth G C Smith; Gavin J Pettigrew
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.